IAD Index of Academic Documents
  • Home Page
  • About
    • About Izmir Academy Association
    • About IAD Index
    • IAD Team
    • IAD Logos and Links
    • Policies
    • Contact
  • Submit A Journal
  • Submit A Conference
  • Submit Paper/Book
    • Submit a Preprint
    • Submit a Book
  • Contact
  • Sakarya Tıp Dergisi
  • Cilt: 15 Sayı: 2
  • Effect of Orlistat Treatment on Visceral Adiposity Index (VAI) in Obese Patients

Effect of Orlistat Treatment on Visceral Adiposity Index (VAI) in Obese Patients

Authors : İhsan Solmaz, Jehat Kılıç, Ömer Faruk Alakuş
Pages : 128-134
Doi:10.31832/smj.1648000
View : 52 | Download : 44
Publication Date : 2025-06-30
Article Type : Research Paper
Abstract :Introduction: Obesity is a chronic disease characterized by excessive fat accumulation. This study aims to assess the impact of orlistat treatment on the visceral adiposity index and related parameters. Material and Method: This study involved 54 patients (18–65 years, BMI >25) from the internal medicine and obesity clinic. Ethical approval and informed consent were obtained. Patients receiving orlistat were monitored at 0, 3, and 6 months. Anthropometric measurements (BMI, weight, waist, and hip circumference) and biochemical markers (glucose, AST, ALT, GGT, TG, HDL) were recorded. VAI was calculated separately for males and females. Results: Clinical and biochemical parameters of 54 patients (F: 52, M: 2) were analyzed. At baseline, mean body weight (103.87±13,01 kg), waist circumference (113.59±10.25 cm), and BMI (41.59±4.86) indicated obesity. Liver enzymes (AST: 20.13 U/L, ALT: 21.87 U/L, GGT: 24.76 U/L) were mostly normal, with slight GGT elevations. Lipid profile showed mean HDL (47.11 mmol/L) and triglycerides (154,89 mg/dL). Over 6 months, significant reductions were observed in weight (93.33±12,44 kg, p<0.01), BMI (37.47±4.61, p<0.01), and waist circumference (105.9±10.2 cm, p<0.01). ALT (p<0.01) and GGT (p<0.001) decreased significantly, while AST did not (p=0.159). HDL improved (p<0.016). VAI slightly decreased (4.42±2.76 to 4.01±2.84), but was not statistically significant (p=0.224). These results suggest weight loss benefits metabolic and liver health. Conclusion: The study observed positive metabolic changes, including weight loss, reduced waist circumference, and decreased BMI. Although VAI showed a decreasing trend after orlistat treatment, the change was not statistically significant. These findings indicate the potential benefits of orlistat.
Keywords : Obesity, Orlistat, Visceral Adiposity Index

ORIGINAL ARTICLE URL

* There may have been changes in the journal, article,conference, book, preprint etc. informations. Therefore, it would be appropriate to follow the information on the official page of the source. The information here is shared for informational purposes. IAD is not responsible for incorrect or missing information.


Index of Academic Documents
İzmir Academy Association
CopyRight © 2023-2026